H1 2023 presentation
How does this Q&A work:
This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Speakers at this event:
10 Questions
Sept. 1, 2023
Kim, how many stocks do you own in the company? Did you sell everything i connection with the capital raise?
Sept. 1, 2023
The market for Digital Dementia treatment was valued at $5 billion in 2022. Do you know how that valuation has been made and what is the other kind og digital dementia treatment methods today that gains the $5 billion in revenue?
Aug. 8, 2023
What is the future plan for the company?, you’ve lost 94% of the market value since u went public, and 70% within the last 3 months.
How does your timeline look to turn the ship around?, to bring some upsite.
Aug. 31, 2023
Can you tell about the benifits of your CST program, compared to other used methods? Is it true, that the users save about 8 hours work, per treatment session?
Sept. 1, 2023
In the future, will you continue to focus on Alzheimers and Dementia, or also move towards other diseases such as Depression?
Aug. 31, 2023
With regard to the subscribtions, already made, can you clearify, wether you have had full subscriptions in these municipalities, or is further subscribtions possible? How is the subscribtions working, is it a one-time fee, or is it a subscribtion fee, that must be renewed?
What are your expectations, with regard to the fundings, that you have applied for?
How is the sales processes in Denmark, Germany and UK developing?
Aug. 29, 2023
Do u have new business planning and how to gain market confidence and protect shareholder’s benefit ?
Aug. 29, 2023
How do you explain why the share price after right issues drop down lot? Why does market not feel confidence about u future ? Any new business development plan ?
Aug. 29, 2023
You stated that the approve of the new Dementia drug by Eisai and Biogen is good news for a company like Brain+. How do you actively plan to take advantage of this drug approval so that the market understands the benefits of combining treatments for Alzheimers and Dementia and you gain the effect not only on paper but in reality as well?
Aug. 29, 2023
In may and june you participated in different conferences what was the outcome of these? Have you gotten any new leads for the product?